ArticleJournal of neuroinflammation2025
Neuro-immune regulation of sepsis-associated delirium via the PBN-CeA-spleen axis.
Article in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sedation as an Immunomodulator of Inflammatory Responses in the Lung-Brain Axis of ARDS.International journal of molecular sciences · 2026Review
- The Neuroimmune Axis in Sepsis: From Pathophysiological Circuits to Precision Neuromodulation.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSepsis associated delirium (SAD) is the most prevalent manifestation of acute brain dysfunction in sepsis, yet its central regulatory mechanisms remain incompletely understood. As researchers have progressively explored the brain-spleen axis and neuroimmunity, this study aimed to investigate the role of the parabrachial nucleus (PBN)-central amygdala (CeA)-spleen axis in the pathogenesis of SAD.
methodsIn a mouse model of SAD induced by intraperitoneal injection of lipopolysaccharide (LPS, 10 mg/kg), we identified activation patterns in both the PBN and CeA using immunofluorescence analysis. We subsequently investigated direct anatomical connections between these regions through bidirectional neural tracing, followed by functional interrogation using fiber photometry and electrophysiological recordings. Finally, we evaluated the effect of targeted inhibition of the PBN-CeA pathway on delirium in septic mice through behavioral assays. Additionally, enzyme-linked immunosorbent assay (ELISA) and flow cytometry were employed for immunological profiling.
resultsWe observed a significant increase in c-Fos expression in both the PBN and CeA, and confirmed a direct anatomical connection between these regions. Fiber photometry and electrophysiological recordings revealed that LPS stimulation activated CeA neurons and splenic sympathetic nerves. In addition, targeted inhibition of the PBN-CeA pathway mitigated CeA calcium dynamics and reduced spontaneous splanchnic nerve discharge. Behavioral assays showed that splenic denervation and inhibition of the PBN-CeA pathway attenuated delirium-like behaviors in septic mice. ELISA and flow cytometry demonstrated that these interventions reversed splenic proinflammatory cytokines (tumor necrosis factor-alpha [TNF-α], interleukin [IL]-1β, IL-6, and IL-10, interferon-gamma [IFN-γ]) and norepinephrine (NE) while restoring immune cell composition and enhancing natural killer (NK) cell function.
conclusionThe PBN-CeA-splenic axis plays a critical neuroimmune conduit linking central neural circuits to peripheral immune modulation, offering new mechanistic insight into the neural regulation of systemic inflammation and the pathogenesis of SAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.